Currently SAGE isn't at a clear support/resistance line that seems tradable. Sage Therapeutics hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the Biotechnology company has lost -37.85 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. SAGE might find some support at the 12 level, buyers might push the price back up from here. But it's not very clear what will happen.
Overall, the analysts have a more negative view on Sage Therapeutics but it's not a very strong negative. The current Analysts Sentiment Score is -25.81. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2024-04-26 Canaccord Genuity Group lowered their price target by -19.05% to $17.00. Mizuho announced a lowering of their price target to $18.00 from $20.00 on 2024-04-26. On 2024-04-26 The Goldman Sachs Group lowered their price target by -32.14% to $19.00. Royal Bank of Canada announced a lowering of their price target to $15.00 from $26.00 on 2024-04-26. Truist Financial decided to move down their price target on 2024-04-26 to $18.00 which is a -18.18% decrease. HC Wainwright announced a lowering of their price target to $25.00 from $28.00 on 2024-04-26. Needham & Company LLC announced that they are reiterating a rating of Hold on 2024-04-25. Oppenheimer announced a lowering of their price target to $17.00 from $25.00 on 2024-04-18. TD Cowen announced a lowering of their price target to $16.00 from $30.00 on 2024-04-18. Scotiabank dropped their price target by -44.12% to $19.00 on 2024-04-18.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
SAGE | -25.81 | 0 | -8.86 | 12.98 | -55.74 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
SAGE | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
SAGE | 12.65 | %19.2 | 5.6 | 2.508 | 9870000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 95 | 0.79 | -3.72 | -2.26 | -0.85 | 7.67 | 40.04 | 55.08 | 6.66 | 6.30 | 3.43 | -14013.76 | -12974.30 | 16.84 | 4.74 | 9.36 | 8.41 |
Healthcare | 230 | 0.88 | -1.52 | -0.30 | -2.16 | 5.72 | 27.64 | 53.66 | 8.86 | 8.57 | 8.32 | -12704.99 | -11984.82 | 18.91 | 4.24 | 6.74 | 5.55 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
SAGE |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TWST | Twist Bioscience Corporat | 1.14 | -0.51 | 5.52 | 2.16 | -6.93 | -0.60 | 73.39 | 57 | 1.93 | 4.07 | 3.73 | 178.09 | -19226.76 | 0 | 0 | 23.3961 |
VCYT | Veracyte, Inc. | 1.12 | 0.13 | 5.83 | 19.59 | 23.97 | 88.10 | 55.68 | 75 | 87.77 | 54.07 | 28.48 | 0.00 | -24528.43 | 150 | 0 | 4.97884 |
DNLI | Denali Therapeutics Inc. | 1.12 | 0.33 | -14.17 | -7.64 | -0.37 | 26.79 | 34.10 | 69 | 74.38 | 103.30 | 59.38 | 116.84 | -22833.86 | 0 | 0 | 11.2371 |
EDIT | Editas Medicine, Inc. Com | 1.1 | -2.82 | -13.00 | -24.21 | -34.51 | -58.66 | -76.19 | 47 | -172.46 | -138.74 | -176.20 | -57394.91 | 2.09 | 0 | 0 | 16.4101 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.